Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Huw Colin-York, Quentin Ferry and Thomas Riffelmacher, who have won this year’s Radcliffe Department of Medicine (RDM) Graduate Prize! The prizes are awarded to current or recently graduated students of RDM supervisors on the basis of exceptional achievement in their research. All three students displayed research excellence during their DPhil studies and have helped to progress their respective fields.

RDM logo

Huw Collin YorkDr Colin-York completed his DPhil with Prof Christian Eggeling and Dr Marco Fritzsche (MRC HIU), investigating biophysical forces in immune cells by combining force measuring techniques with super-resolution microscopy. He was awarded the Prize for developing a methodology to study T cell activation, which may lead to changes in the field, and establishing a valuable strategic collaboration. Huw was also commended for his dedication to teaching microscopy skills to school pupils and to overseas researchers. Learn more about his work here.

 

Quentin FerryDr Ferry completed his DPhil with Associate Prof Tudor Fulga, employing RNA-engineering to develop novel inducible CRISPR/Cas9 systems, whose activity can be conditioned on genetically encoded, or externally delivered, triggers. He was awarded the Prize for developing and applying new methods in genome editing, which promise to progress the field. Learn more about his work here.

 

Thomas RiffelmacherDr Riffelmacher completed his DPhil with Prof Sten Eirik Jacobsen (MRC MHU) and Prof Katja Simon (MRC HIU). He explored the role that autophagy, a cellular recycling pathway, has during the differentiation of blood and immune cells. He was awarded the Prize for establishing a new mechanism by which autophagy controls differentiation and for his entrepreneurial spirit. Learn more about his work here.

 

All three winners receive £500 and will speak at the RDM Symposium on 19 March 2018.

Find out more about the RDM Graduate Prize and previous winners here.

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.

Immune cells imperfect at distinguishing friend from foe

When it comes to distinguishing a healthy cell from an infected one that needs to be destroyed, the immune system’s killer T cells sometimes make mistakes. This discovery, described today in the journal eLife, upends a long-held belief among scientists that T cells were nearly perfect at discriminating friend from foe. The results may point to new ways to treat autoimmune diseases that cause the immune system to attack the body, or lead to improvements in cutting-edge cancer treatments.

Professor Graham Ogg elected Academy of Medical Sciences Fellow

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.